Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel electrochemical method for benzyl isothiocyanates offers mild conditions and high purity for reliable pharmaceutical intermediate supply chains.
Patent CN110642897A reveals a novel, scalable synthesis for beta-nicotinamide riboside chloride. High-purity NRC precursor for NMN manufacturing without chromatography.
Patent CN104693063A reveals high-yield Tranilast synthesis. Discover cost-effective scalable routes for pharmaceutical intermediates supply chain optimization.
Patent CN103709221A details a high-yield cordycepin synthesis using adenosine. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel one-pot method reduces polymer by-products and enhances yield for high-purity dihydrolipoic acid manufacturing with scalable supply chain reliability.
Patent CN110845371A reveals a novel ambient pressure synthesis for o-sulfonic acid benzaldehyde, offering significant cost reduction and safer manufacturing for pharmaceutical intermediates.
Patent CN101412706B details a high-purity 1,3-dihydroxyacetone synthesis from glycerol. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel two-step process for high-purity dabigatran impurity without chromatography ensures cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN110590821A details mild iridium-catalyzed synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with stable raw materials and high purity.
Patent CN110256489B reveals a mild copper-catalyzed route for alkyl phosphonyl compounds, offering cost reduction in pharmaceutical intermediate manufacturing and safer supply chains.
Efficient regioselective synthesis method for sugar derivatives enabling cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
High-yield preparation method using industrially available salts ensures cost reduction and supply chain reliability for global pharmaceutical and agrochemical manufacturers.
Patent CN103224467A details a cost-effective resolution method for (-)-Huperzine A, achieving >99.5% purity and significantly reducing manufacturing costs for pharmaceutical applications.
Novel one-pot synthesis of alpha-diketones from propargyl alcohols and anhydrides using metal salts. Mild conditions, high yield, cost-effective for pharma intermediates.
Novel gradient heating synthesis for Tenofovir Alafenamide intermediates. High yield, reduced waste, scalable production for pharmaceutical supply chains.
Patent CN120817990A details a column-free purification method for DMTr uridine, ensuring high purity and yield for scalable nucleic acid intermediate manufacturing.
Patent CN118084876A reveals a concise Pauson-Khand route for indole skeletons. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Advanced synthesis of antiviral intermediate QD-Z0212 via patent CN102603658B. High-yield, scalable process for pharmaceutical manufacturing supply chains.
Novel patent CN114716411B enables efficient mother liquor recovery for dabigatran etexilate mesylate. Achieve high purity without chromatography, ensuring cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1130343C reveals a high-yield synthesis of indolyl-3-acetamide from indomethacin, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.